Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

Candel Therapeutics (CADL) Shares Issued (2020 - 2025)

Candel Therapeutics' Shares Issued history spans 3 years, with the latest figure at $36000.0 for Q4 2022.

On a quarterly basis, Shares Issued rose 100.05% to $36000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $64000.0, a 85.12% decrease, with the full-year FY2025 number at $516000.0, down 69.45% from a year prior.
Shares Issued hit $36000.0 in Q4 2022 for Candel Therapeutics, up from $22000.0 in the prior quarter.
Over the last five years, Shares Issued for CADL hit a ceiling of $71.3 million in Q3 2021 and a floor of -$70.9 million in Q4 2021.
Historically, Shares Issued has averaged $74714.3 across 3 years, with a median of $29000.0 in 2020.
Biggest five-year swings in Shares Issued: crashed 244600.0% in 2021 and later soared 100.05% in 2022.
Tracing CADL's Shares Issued over 3 years: stood at $29000.0 in 2020, then crashed by 244600.0% to -$70.9 million in 2021, then skyrocketed by 100.05% to $36000.0 in 2022.
Business Quant data shows Shares Issued for CADL at $36000.0 in Q4 2022, $22000.0 in Q2 2022, and $6000.0 in Q1 2022.